Camden National Corporation’s Pfizer PFE Stock Holding History

Camden National Corporation’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$565K	Buy	+15,574	New	+$553K	0.11%	86

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Camden National Corporation's PFE Position: Q1 2021 in Review

Camden National Corporation opened a new position in Pfizer (PFE) in Q1 2021: 15,574 shares worth $565K. The stake represents 0.11% of the portfolio and ranks #86 among its holdings.

2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

Camden National Corporation held 15,574 shares of Pfizer worth $565K as of Q1 2021.
Pfizer was a new Camden National Corporation position in Q1 2021.
Pfizer made up 0.11% of Camden National Corporation's portfolio in Q1 2021, its #86 holding.
2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on Camden National Corporation's 13F filing for Q1 2021, filed 12 May 2021.